Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer

Kievit, 2002, Follow-up of patients with colorectal cancer: numbers needed to test and treat, Eur J Cancer, 38, 986, 10.1016/S0959-8049(02)00061-8

Flamini, 2006, Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer, Clin Cancer Res, 12, 6985, 10.1158/1078-0432.CCR-06-1931

Gold, 1965, Specific carcinoembryonic antigens of the human digestive system, J Exp Med, 122, 467, 10.1084/jem.122.3.467

van der Schouw, 1992, Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma, Br J Cancer, 66, 148, 10.1038/bjc.1992.233

George, 1982, Circulating CEA levels in patients with fulminant hepatitis, Dig Dis Sci, 27, 139, 10.1007/BF01311707

Rockall, 1999, Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer, Int J Colorectal Dis, 14, 73, 10.1007/s003840050188

Moertel, 1993, An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer, JAMA, 270, 943, 10.1001/jama.270.8.943

Wang, 1994, Value of carcinoembryonic antigen in the management of colorectal cancer, Dis Colon Rectum, 37, 272, 10.1007/BF02048166

Kievit, 1990, Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analysis, Cancer, 65, 2580, 10.1002/1097-0142(19900601)65:11<2580::AID-CNCR2820651131>3.0.CO;2-I

Vignati, 1993, Preoperative evaluation and postoperative surveillance for patients with colorectal carcinoma, Surg Clin North Am, 73, 67, 10.1016/S0039-6109(16)45929-3

Hida, 1996, Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques, Dis Colon Rectum, 39, 74, 10.1007/BF02048273

Kelly, 1992, Colorectal cancer. Principles of postoperative follow-up, Cancer, 70, 1397, 10.1002/1097-0142(19920901)70:3+<1397::AID-CNCR2820701531>3.0.CO;2-A

Barillari, 1991, Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences, Aust N Z J Surg, 61, 675, 10.1111/j.1445-2197.1991.tb00319.x

Bossuyt, 2003, Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative, BMJ, 326, 41, 10.1136/bmj.326.7379.41

Whiting, 2003, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, BMC Med Res Methodol, 3, 25, 10.1186/1471-2288-3-25

Littenberg, 1993, Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method, Med Decis Making, 13, 313, 10.1177/0272989X9301300408

Moses, 1993, Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations, Stat Med, 12, 1293, 10.1002/sim.4780121403

Walter, 2002, Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data, Stat Med, 21, 1237, 10.1002/sim.1099

Irwig, 1994, Guidelines for meta-analyses evaluating diagnostic tests, Ann Intern Med, 120, 667, 10.7326/0003-4819-120-8-199404150-00008

Jaeschke, 1994, Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-based medicine working group, JAMA, 271, 389, 10.1001/jama.271.5.389

Jaeschke, 1994, Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The evidence-based medicine working group, JAMA, 271, 703, 10.1001/jama.271.9.703

Lucha, 1997, Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma, Dis Colon Rectum, 40, 145, 10.1007/BF02054978

Seregni, 1992, The role of serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the Istituto Tumori of Milan, Int J Biol Markers, 7, 167, 10.1177/172460089200700308

Begg, 1988, Assessment of radiologic tests: control of bias and other design considerations, Radiology, 167, 565, 10.1148/radiology.167.2.3357976

Vyslouzil, 2004, Oncologic markers in patients with colorectal cancer after a complex therapy, Bratisl Lek Listy, 105, 389

Hall, 1994, The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer, Br J Cancer, 70, 549, 10.1038/bjc.1994.343

Meling, 1992, Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients, Scand J Gastroenterol, 27, 1061, 10.3109/00365529209028139

Staib, 2000, Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts, Langenbecks Arch Surg, 385, 412, 10.1007/s004230000144

Korner, 2006, Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis, Ann Surg Oncol

Bronstein, 1980, The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy, Cancer, 46, 266, 10.1002/1097-0142(19800715)46:2<266::AID-CNCR2820460208>3.0.CO;2-J

Park, 2006, Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer, Ann Surg Oncol, 13, 645, 10.1245/ASO.2006.03.090

Arnaud, 1980, Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma, Dis Colon Rectum, 23, 141, 10.1007/BF02587615

Bleeker, 2001, Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer, Br J Surg, 88, 101, 10.1046/j.1365-2168.2001.01638.x

Martin, 1980, Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen, J Surg Res, 28, 389, 10.1016/0022-4804(80)90100-6

Goslin, 1981, Correlation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer, Am J Med, 71, 246, 10.1016/0002-9343(81)90125-X

Moertel, 1986, The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer, Cancer, 58, 603, 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K

Chau, 2004, The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer, J Clin Oncol, 22, 1420, 10.1200/JCO.2004.05.041

Arnaud, 1997, Value of oncologic follow-up of patients operated for colorectal cancer. A prospective study of 1000 patients, J Chir (Paris), 134, 45

Rocklin, 1990, Postoperative surveillance of patients with carcinoma of the colon and rectum, Am Surg, 56, 22

Carpelan-Holmstrom, 2004, CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer, Tumour Biol, 25, 228, 10.1159/000081385

Griesenberg, 1999, Cea, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer, Anticancer Res, 19, 2443

Holubec, 2000, The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence, Anticancer Res, 20, 5237

Nicolini, 1995, Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the diagnosis of primary colorectal cancer and at its relapse, Cancer Detect Prev, 19, 183

Fernandes, 2006, Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer, World J Gastroenterol, 12, 3891, 10.3748/wjg.v12.i24.3891

Miki, 2006, Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study, Dis Colon Rectum, 49, 1710, 10.1007/s10350-006-0697-9

Behbehani, 1990, Serial determinations of serum CEA in monitoring management of patients with colorectal carcinoma, Oncology, 47, 303, 10.1159/000226838

Li Destri, 1998, Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?, Surg Today, 28, 1233, 10.1007/BF02482805

McCall, 1994, The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer, Dis Colon Rectum, 37, 875, 10.1007/BF02052591

Novell, 1997, Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen, Anticancer Res, 17, 2743

Staib, 2000, Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?, Am J Surg, 180, 1

Barillari, 1994, Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: prospective study of 174 patients undergoing radical surgery, Minerva Chir, 49, 953

Engaras, 2001, CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease, Eur J Surg Oncol, 27, 43, 10.1053/ejso.2000.1027

Ishikawa, 1999, Tumor angiogenesis predicts recurrence with normal serum carcinoembryonic antigen in advanced rectal carcinoma patients, Surg Today, 29, 983, 10.1007/s005950050633

Tobaruela, 1997, Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level, Int J Biol Markers, 12, 18, 10.1177/172460089701200104

Filella, 1994, Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA, Tumour Biol, 15, 1, 10.1159/000217867

Hung, 2001, Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer, Anticancer Res, 21, 1375

Spila, 2001, Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation, Anticancer Res, 21, 1263